Health

Co-founded by Stanford researchers, IgGenix is working on therapies that address severe allergies.

Based on research originally conducted at MIT, Tepha has been purchased by BD for an undisclosed sum.

UPMC Enterprises has contributed to a $117m series B round for gene therapy developer Ring Therapeutics.

Topas Therapeutics has almost doubled its series B round to $48m thanks to an extension backed by all of its shareholders.

Cornell-linked dog DNA test developer Embark Veterinary raised the capital in a round led by SoftBank Vision Fund 2 at a $700m post-money valuation.

Imec.xpand has returned to back a series B round for sleep diagnostic developer Onera Health, spun out of Imec.

IP Group is among the investors backing the DDR cancer therapeutics developer’s latest round, which took its total funding to $320m.

SoftBank has contributed to a $350m private placement supporting the health screening provider's reverse takeover.

M Ventures, Novartis Venture Fund and Pfizer Ventures are among the investors backing the DDR cancer therapeutics developer’s latest round, which took its total funding to $320m.

Icahn School of Medicine spinout Sema4 has completed a reverse merger with CM Life Sciences to begin trading on the Nasdaq Global Select Market.

Denso took part in a $71m series D round for artificial intelligence technology provider Blaize while inflammatory disease drug developer Aristea closed a $63m Novo and Arena-backed round.